Phaeochromocytoma and paraganglioma.
| Autor: | Tarling JA; Clinical Biochemistry, Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK julie.tarling@bedfordhospital.nhs.uk., Kumar R; Diabetes and Endocrinology, Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK., Ward LJ; Clinical Biochemistry, Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK., Boot C; Blood Sciences, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK., Wassif WS; Clinical Biochemistry, Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of clinical pathology [J Clin Pathol] 2024 Jul 18; Vol. 77 (8), pp. 507-516. Date of Electronic Publication: 2024 Jul 18. |
| DOI: | 10.1136/jcp-2023-209234 |
| Abstrakt: | Phaeochromocytomas and paragangliomas are rare catecholamine-producing neuroendocrine tumours which can potentially cause catastrophic crises with high morbidity and mortality. This best practice article considers the causes and presentation of such tumours, screening and diagnostic tests, management of these patients and consideration of family members at risk. Competing Interests: Competing interests: None declared. (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|